The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.
Cinnamon is one of the most extensively studied spices in terms of potential health benefits. This review examines the scientific evidence for cinnamon's therapeutic properties, appropriate dosing, safety considerations, and commercial applications.
Image source and license: https://commons.wikimedia.org/wiki/File:Cinnamomum_zeylanicum_%28Cinnamon%29_tree_in_RDA,_Bogra_01.jpg.
Modified by Peter Jorgensen.
The term "cinnamon" commonly refers to two main species, which are often confused but have different chemical compositions and potentially different health effects:
A critical distinction is that Cassia cinnamon contains significantly higher levels of coumarin, a naturally occurring compound that may cause liver damage when consumed in large amounts, compared to Ceylon cinnamon.
Cinnamon's therapeutic effects are primarily attributed to these bioactive compounds:
Based on recent systematic reviews and meta-analyses, cinnamon has demonstrated the following effects with varying levels of evidence:
Clinical studies have utilized varying dosages, making standardized recommendations challenging. However, based on the available evidence:
Important note: Standardization of cinnamon preparations varies widely across studies, making direct comparisons difficult. When possible, preparations standardized to cinnamaldehyde content (typically 1-2%) or type-A polyphenols are preferred for therapeutic purposes.
Few studies have systematically investigated dose-response relationships for cinnamon. The available evidence suggests:
Studies examining high-dose cinnamon extracts have primarily focused on acute toxicity rather than enhanced efficacy. This represents a notable gap in the research literature.
Cinnamon is generally recognized as safe (GRAS) by the FDA when used in typical culinary amounts. However, therapeutic doses may present certain risks:
The European Food Safety Authority has established a Tolerable Daily Intake (TDI) for coumarin at 0.1 mg/kg body weight. For a 70 kg adult, this equates to approximately 7 mg of coumarin, which could be exceeded by consuming just 1-2 g of Cassia cinnamon daily.
Cinnamon shows promising therapeutic potential for several health conditions, particularly for glycemic control, lipid profile improvement, and as an antioxidant. However, the quality of evidence varies considerably across health claims. The distinction between Ceylon and Cassia cinnamon is critical when considering therapeutic applications due to safety concerns with coumarin content in Cassia varieties. More research is needed to establish optimal dosing regimens, standardization methods, and to investigate potential drug interactions.
Allen, R. W., Schwartzman, E., Baker, W. L., Coleman, C. I., & Phung, O. J. (2013). Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. The Annals of Family Medicine, 11(5), 452-459.
Costello, R. B., Dwyer, J. T., Saldanha, L., Bailey, R. L., Merkel, J., & Wambogo, E. (2016). Do cinnamon supplements have a role in glycemic control in type 2 diabetes? A narrative review. Journal of the Academy of Nutrition and Dietetics, 116(11), 1794-1802.
Hajimonfarednejad, M., Nimrouzi, M., Heydari, M., Zarshenas, M. M., Raee, M. J., & Jahromi, B. N. (2018). Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double‐blind placebo controlled clinical trial. Phytotherapy Research, 32(2), 276-283.
Kawatra, P., & Rajagopalan, R. (2015). Cinnamon: Mystic powers of a minute ingredient. Pharmacognosy research, 7(Suppl 1), S1.
Khan, A., Safdar, M., Ali Khan, M. M., Khattak, K. N., & Anderson, R. A. (2003). Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes care, 26(12), 3215-3218.
Kim, J. I., Lee, J. H., Song, Y., Kim, Y. T., Lee, Y. H., & Kang, H. (2018). Oral consumption of cinnamon enhances the expression of immunity and lipid absorption genes in the small intestinal epithelium and alters the gut microbiota in normal mice. Journal of Functional Foods, 49, 96-104.
Mousavi, S. M., Rahmani, J., Kord-Varkaneh, H., Sheikhi, A., Larijani, B., & Esmaillzadeh, A. (2020). Cinnamon supplementation positively affects obesity: A systematic review and dose-response meta-analysis of randomized controlled trials. Clinical Nutrition, 39(1), 123-133.
Zhang, C., Fan, L., Fan, S., Wang, J., Luo, T., Tang, Y., ... & Yu, L. (2019). Cinnamomum cassia Presl: A review of its traditional uses, phytochemistry, pharmacology and toxicology. Molecules, 24(19), 3473.